Now playing Next Business Novo Nordisk looks to expand into heart disease treatment The Novo Nordisk deal is due to be wrapped up in the second quarter of this year. It will help to establish the maker of Wegovy and Ozempic in the cardiovascular treatment market. 26/03/2024
Now playing Next Health news EU Policy. Parliament calls for extended regulatory protection for pharmacos The committee on environment and public health voted to increase the Commission’s proposal for regulatory protection for new pharmaceutical legislation by one-and-a-half years. 20/03/2024
Now playing Next Health news EU Policy. Parliament approach to IP rights amid health crises raises critics An EU-wide mechanism to override IP rights to deliver live-saving medicines during crises will prove tricky to enforce if amendments proposed by MEPs are retained, intellectual property rights experts warn. 14/03/2024
Now playing Next Business Novo Nordisk expands lead on Tesla on upbeat obesity drug trial Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy. 08/03/2024
Now playing Next Economy Denmark's GDP soars thanks to growing pharma sector Denmark's gross domestic product (GDP) grew 2% in the fourth quarter of 2023, largely bolstered by the country's expanding pharmaceutical sector. 20/02/2024
Now playing Next Markets Novo Nordisk crossroads: Can the pharma giant address the supply woes? Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision. 10/02/2024
Now playing Next The Big Question Novartis doctor on Big Pharma’s battle against climate change If the healthcare industry was a country, it would be the fifth largest polluter on Earth. 01/02/2024
Now playing Next Business Drugmaker Novo Nordisk reaches market value of $500 million Demand for obesity drugs has pushed Novo Nordisk's share price to new highs. 31/01/2024
Now playing Next Green News EU Policy. Pharma and cosmetics industries to pay for wastewater treatment ‘Polluter pays’ principle mandates key industries to take responsibility for spreading micropollutants. 30/01/2024
Now playing Next Health news €2.5 million drug now approved in Ireland, Belgium and the Netherlands Libmeldy - a treatment for a rare disease costing €2.5 million - has become available in Ireland, Belgium and the Netherlands. 26/01/2024
Now playing Next Health news 'I’m scared': UK patients struggle to access epilepsy medication A national shortage of some epilepsy medications in the UK is putting patients' safety at risk. 23/01/2024
Now playing Next Health news Scientists discover first new antibiotics in over 60 years using AI A new class of antibiotics for drug-resistant Staphylococcus aureus (MRSA) bacteria which was discovered using more transparent deep learning models. 31/12/2023
Now playing Next Health news AI could change the game for drug development Biotech startups are using AI to speed drug discovery, revolutionising pharmaceuticals. Iktos aims to halve pre-clinical drug discovery time. 07/12/2023
Now playing Next Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Now playing Next Health news Australia has apologised to thalidomide survivors. What about Europe? The Australian government issued formal apologies to victims of thalidomide this week. In Europe, the recognition of victims has been heterogeneous. 01/12/2023
Now playing Next Business Denmark's Novo Nordisk invests €2.1 billion in France Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug. 24/11/2023
Now playing Next France Five hundred new jobs coming in Chartres, south of Paris On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the capacity and manufacturing of a blockbuster anti-obesity drug. 24/11/2023
Now playing Next Healthcare France debates amendment on biomedicine substitution in pharmacies An amendment is being debated on whether pharmacies can substitute approved replacements for biological medicines, but patient organisations have raised concerns. 15/11/2023
Now playing Next Business AstraZeneca announces new anti-obesity drug deal and positive profit AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug. 10/11/2023
Now playing Next Health news Growing drugs shortage is leaving pharmacists and patients in the dark Shortages of common older medicines are increasing. Experts say it’s in part because pharmaceutical companies are de-incentivised from producing them. 10/10/2023
